bicyclo(FΦR4-A5)Rho

General Information


DRACP ID  DRACP05452

Peptide Name   bicyclo(FΦR4-A5)Rho

Sequence  XAAAAAKRRRRΦFXKX

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Ala2<--->Ala6; Arg8<--->Phe13

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B

Chiral  Mix



Physicochemical Information


Formula  C60H100N26O9

Absent amino acids  CDEGHILMNPQSTVWY

Common amino acids  A

Mass  192735

Pl  12.98

Basic residues  6

Acidic residues  0

Hydrophobic residues  6

Net charge  6

Boman Index  -5875

Hydrophobicity  -87.5

Aliphatic Index  31.25

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24896852

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2251

DRACP is developed by Dr.Zheng's team.